Loading clinical trials...
Loading clinical trials...
The purpose of the trial is to detect tumor microenvironment on Extensive Stage Small Cell Lung Cancer with simultaneous liver metastases who Treated with Atezolizumab plus Etoposide and Platinum Base...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Hunan Province Tumor Hospital
NCT07037758 · Extensive Stage Small Cell Lung Cancer
NCT05142696 · Extensive Stage Small Cell Lung Cancer
NCT05468489 · Extensive Stage Small Cell Lung Cancer
NCT07547332 · Small Cell Lung Cancer, Extensive Stage Small Cell Lung Cancer (ES-SCLC)
NCT06323265 · Extensive Stage Small Cell Lung Cancer
Hunan Cancer Hospital
Changsha, Hunan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions